Tax or exercise withholding
Mark Kaye
EVP & CFO
Common Stock
- Value context
- $1.61M
- Reported price
- $386.43 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Elevance Health, Inc.
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
Showing the first 6 of 20 trades on this page.
EVP & CFO
Common Stock
EVP & CFO
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
$752,554 of common-equity purchase value after transaction-age decay across 180 days.
2 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.
Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.
At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
EVP & Chief Legal Officer
Common Stock
EVP & Chief Legal Officer
Common Stock
EVP & Chief HR Officer
Common Stock
Director
Common Stock
President and CEO
Common Stock
President and CEO
Common Stock
CAO & Controller
Common Stock
Director
Common Stock
CAO & Controller
Common Stock
CAO & Controller
Common Stock
CAO & Controller
Common Stock
CAO & Controller
Employee Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
CAO & Controller
Employee Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| EVP & CFO | Common StockExercise-price or tax withholding | 4,161$386.43 / share | $1.61M | Oct 2Filed Oct 6 · 4d later | SEC filing |
| EVP & CFO | Common StockGrant or award | 2,627Award · no purchase price | Non-cash award | Oct 2Filed Oct 6 · 4d later | SEC filing |
| EVP & Chief Legal Officer | Common StockExercise-price or tax withholding | 94$405.84 / share | $38.15K | Sep 2Filed Sep 4 · 2d later | SEC filing |
| EVP & Chief Legal Officer | Common StockExercise-price or tax withholding | 255$414.78 / share | $105.77K | Sep 3Filed Sep 4 · 1d later | SEC filing |
| EVP & Chief HR Officer | Common StockExercise-price or tax withholding | 144$405.84 / share | $58.44K | Sep 2Filed Sep 4 · 2d later | SEC filing |
| Director | Common StockPurchase | 1,000$366.05 / share | $366.05K | Jul 17Filed Jul 17 · 0d later | SEC filing |
| President and CEO | Common StockPurchase2 trades | 2,725avg $367.79 / share | $1M | Jul 17Filed Jul 17 · 0d later | 2 filings
|
| CAO & Controller | Common StockSale | 369$403.16 / share | $148.77K | Jun 12Filed Jun 15 · 3d later | SEC filing |
| Director | Common StockSale | 151$401.77 / share | $60.67K | Jun 11Filed Jun 12 · 1d later | SEC filing |
| CAO & Controller | Common StockOption exercise or conversion | 654$271.27 / share | $177.41K | May 19Filed May 20 · 1d later | SEC filing |
| CAO & Controller | Common StockOption exercise or conversion | 877$311.48 / share | $273.17K | May 19Filed May 20 · 1d later | SEC filing |
| CAO & Controller | Common StockSale | 1,531$403.13 / share | $617.19K | May 19Filed May 20 · 1d later | SEC filing |
| CAO & Controller | Employee Stock Option (Right to Buy)Option exercise or conversion | Derivative units654$271.27 exercise / conversion price | Not a separate purchase | May 19Filed May 20 · 1d later | SEC filing |
| CAO & Controller | Employee Stock Option (Right to Buy)Option exercise or conversion | Derivative units877$311.48 exercise / conversion price | Not a separate purchase | May 19Filed May 20 · 1d later | SEC filing |
| Director | Common StockGrant or award | 563Award · no purchase price | Non-cash award | May 13Filed May 15 · 2d later | SEC filing |
| Director | Common StockGrant or award | 563Award · no purchase price | Non-cash award | May 13Filed May 15 · 2d later | SEC filing |
| Director | Common StockGrant or award | 563Award · no purchase price | Non-cash award | May 13Filed May 15 · 2d later | SEC filing |
| Director | Common StockGrant or award | 563Award · no purchase price | Non-cash award | May 13Filed May 15 · 2d later | SEC filing |
| Director | Common StockGrant or award | 563Award · no purchase price | Non-cash award | May 13Filed May 15 · 2d later | SEC filing |
Showing the latest 20 of 25 trades. Show all 25 trades
Elevance Health, Inc. Common Stock · Stock
The filing reports a purchase for the member.
Elevance Health, Inc. Common Stock · Stock
The filing reports a purchase for a joint account.
Markwayne MullinReporting Senate member